BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...

Jessie J, who shared her breast cancer diagnosis in June and underwent surgery this summer, said she's been "crying a lot" as ...

In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Peptidream Inc. has announced a new radiopharmaceutical candidate targeting cadherin-3 (CDH3) for the diagnosis and treatment of head and neck squamous cell carcinoma.

Incyte (INCY) announced the Japan Ministry of Health, Labour and Welfare approval of Zynyz in combination with carboplatin and paclitaxel for the ...

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based ...

Anal cancer is often linked to HPV, with squamous cell carcinoma being the most common type. Diagnosis involves exams, ...

"Gideon is a huge part of our family, and now we don’t have to say goodbye for a long time," Hayley Glatfelter told Newsweek.

Taylor Swift's backup singer Jeslyn Gorman, who joined the team in 2018, shared her experience being diagnosed with breast cancer in the middle of the Eras Tour.